Collaboration - October 17, 2014
AstraZeneca, MedImmune and the University of Cambridge in new collaborations
AstraZeneca, together with its global biologics research and development arm, MedImmune, has entered into four new collaborations with the University of Cambridge, building further on their existing partnership. The new agreements build on the existing partnership between AstraZeneca, MedImmune and the University of Cambridge, which includes an oncology research programme and co-location of AstraZeneca scientists […]
Collaboration - March 13, 2014
Medimmune collaborates with University of Cambridge
Medimmuneand the University of Cambridge have entered into a three-year oncology research collaboration. The aim of the partnership is to advance cancer research by using imaging technologies to measure key biologic changes within growing tumours. Under the agreement, Medimmune will contribute both funding and a post-doctoral scientist to work within the laboratory of Professor Kevin Brindle at […]
